Now, a new study will examine how to best get recommendations from expert committees and journal articles and into clinics where they can help patients.The Duke Clinical Research Institute will lead a research program, COORDINATE-Diabetes (COOrdinating C https://www.ajmc.com/newsroom/duke-study-to-examine-how-diabetes-cardiovascular-guidelines-get-into-clinical-practice

JDRF, the leading global organization funding type 1 diabetes (T1D) research, announced today that it made progressive advances this year on its path to a cure, funding new therapeutic developments to better treat the chronic autoimmune disease affecting https://www.prnewswire.com/news-releases/jdrf-drives-next-generation-type-1-diabetes-research-with-new-partnerships–breakthrough-science-300769653.html

TriNetX, the global health research network that revolutionizes clinical research and enables discoveries through the creation of real-world evidence (RWE), today announced the results of a study confirming that the TriNetX platform successfully leverage https://www.prnewswire.com/news-releases/trinetx-real-world-evidence-platform-validates-outcomes-of-randomized-clinical-trials-300767717.html

I-Mab Biopharma and CSPC Pharmaceutical Group jointly announced a strategic partnership between the two companies. Under the partnership, I-Mab’s will grant an exclusive license to CSPC to develop I-Mab’s long-acting GLP-1 Fc program (TG103) in C https://www.biospace.com/article/releases/i-mab-and-cspc-pharma-announce-strategic-partnership-for-long-acting-glp-1-fc-program/

Making its second appearance at CES, the world’s leading technology event, on 8-11 January 2019 at Las Vegas, the Grenoble-based firm Diabeloop, invited by the CEA, will present its plan to adapt its machine-learning adult diabetes management system https://markets.businessinsider.com/news/stocks/diabeloop-at-ces-in-las-vegas-to-present-its-groundbreaking-automated-insulin-delivery-system-for-type-1-diabetes-1027813936